SUBLOCADE Rapid Initiation Study

NCT03993392 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: TM buprenorphine
DRUG: SUBLOCADE

Sponsor

Indivior Inc.